Rate My Professor Bronwyn Berthon

The foundation of Berthon's research program lies in nutrition-focused clinical trials that explore the metabolic, immunological, and biochemical relationships between dietary intake, obesity, inflammation, and respiratory diseases, with a particular emphasis on asthma. Her expertise spans clinical trial execution, dietary intake and nutritional biomarker assessment, and clinical evaluation of airways disease, complemented by collaborations with discovery scientists on mechanistic pathways in asthma and obesity. Notable publications include 'Oral lactoferrin reduces systemic inflammation, enhances anti-viral responses and modulates immune cell profiles: an RCT in healthy, older adults' (British Journal of Nutrition, 2026), 'Pilot investigation of an oligosaccharide blend in adults with asthma – a double-blind, randomised, placebo-controlled, 4-arm crossover trial' (Respiratory Medicine, 2025), and 'Weight Loss and Short-Chain Fatty Acids Reduce Systemic Inflammation in Monocytes and Adipose Tissue Macrophages from Obese Subjects' (Nutrients, 2022). She has led discoveries such as soluble fibre as an anti-inflammatory treatment for asthma and fruit and vegetable intake reducing asthma risk. Berthon has secured 21 grants totaling $3,800,129, including NHMRC funding for immunometabolic mechanisms in asthma-COPD overlap. Awards include Best Oral Presentation in Asthma and Allergy at the Thoracic Society of Australia and New Zealand Annual Scientific Meeting (2021), Ann Woolcock Young Investigator Award finalist (2013), Asthma Foundation of New South Wales Khancoban International Travel Award (2012), and Vice-Chancellor's Award for Outstanding Research Candidates (2010). Her vision is to develop dietary guidelines for individuals with respiratory conditions through novel clinical trials.